Genetic approaches for elucidation of mechanisms by which BMP7 downregulates MGMT, ABC efflux transporters, stemness, and EMT would further facilitate our understanding the process and ability to identify new treatment targets and strategies for preventing treatment resistance and tumor recurrence. The gene discussed is MGMT; the disease is neoplasm.